Latest Breaking News On - மோனிகா பெரெஸ் - Page 19 : comparemela.com

Press release content from Business Wire. The AP news staff was not involved in its creation. Noven to Present Pivotal Study Results for Investigational Dextroamphetamine Transdermal System for Pediatric ADHD Patients April 27, 2021 GMT MIAMI & JERSEY CITY, N.J. (BUSINESS WIRE) Apr 27, 2021 Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced it will present the results of a multicenter, phase 2, laboratory classroom study which evaluated the safety and efficacy of its investigational dextroamphetamine transdermal system (“ATS”) in over 100 pediatric patients (ages 6-17 years) with ADHD at the 2021 virtual American Psychiatric Association (APA) Annual Meeting May 1-3, 2021.

United statesMonica perezAndrewj cutlerJoel lippmanAmerican psychiatric associationHisamitsu pharmaceutical co incDrug administrationLaboratory classroom study to evaluate the safetyNeuroscience education instituteNoven pharmaceuticals incAnnual meeting mayLaboratory classroom studyAmphetamine transdermal drug delivery systemPelham scaleDextroamphetamine transdermal systemAdolescents with